Werlinich Asset Management, LLC Medtronic PLC Transaction History

Werlinich Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$79.47 - $91.38 $1.17 Million - $1.34 Million	-14,700 Closed	0 $0
Q1 2023 Nov 13, 2023	SELL	$76.72 - $87.58 $56,005 - $63,933	-730 Reduced 4.73%	14,700 $1.19 Billion
Q4 2022 Nov 13, 2023	SELL	$76.18 - $87.74 $25,901 - $29,831	-340 Reduced 2.16%	15,430 $1.2 Billion
Q3 2022 Nov 13, 2023	SELL	$80.75 - $95.31 $10,093 - $11,913	-125 Reduced 0.79%	15,770 $1.27 Billion
Q2 2022 Nov 13, 2023	BUY	$87.4 - $113.09 $874 - $1,130	10 Added 0.06%	15,895 $1.43 Billion
Q4 2021 Nov 13, 2023	BUY	$99.53 - $127.75 $114,459 - $146,912	1,150 Added 7.8%	15,885 $1.64 Billion
Q1 2021 Nov 13, 2023	BUY	$111.18 - $119.74 $1.64 Million - $1.76 Million	14,735 New	14,735 $1.74 Billion

2,223

1.04B

7.09M

4.39M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Werlinich Asset Management, LLC with notifications on news.